Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Zh. Z. Rakhmanova"'
Autor:
A. S. Frolova, A. G. Volkova, O. V. Paina, P. V. Kozhokar, K. A. Ekushov, Zh. Z. Rakhmanova, L. A. Cvetkova, E. D. Dobrovolskaya, B. I. Smirnov, E. A. Kulagin, T. A. Bykova, E. V. Semenova, L. S. Zubarovskaya
Publikováno v:
Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, Vol 29, Iss 3, Pp 81-90 (2022)
Relevance. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) makes it possible to treat severe malignant and non-malignant hematopoietic disorders system. Pulmonary complications (PC) occur in 40–60 % of patients after allo-HSCT. Howev
Externí odkaz:
https://doaj.org/article/4798da693be74e02beec0aebcaf1a834
Autor:
A. S. Borovkova, O. V. Paina, P. V. Kozhokar, Zh. Z. Rakhmanova, A. A. Osipova, L. A. Tsvetkova, T. A. Bykova, O. A. Slesarchuk, I. S. Moiseev, E. V. Semenova, A. D. Kulagin, L. S. Zubarovskaya
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 22:32-43
Acute myeloid leukemia (AML) is the second most common type of leukemia in children and accounts for up to 20 % of all leukemias. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective, and sometimes the only therapeutic optio
Autor:
L. A. Tsvetkova, A. V. Evdokimov, I. M. Barkhatov, O. V. Paina, O. S. Epifanovskaya, E. V. Babenko, N. E. Ivanova, Zh. Z. Rakhmanova, P. V. Kozhokar, A. S. Frolova, A. A. Osipova, S. V. Ryabenko, D. V. Kozlov, T. L. Gindina, E. V. Semenova, A. D. Kulagin, L. S. Zubarovskaya
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 22:44-53
The loss of a patient-specific HLA haplotype on the surface of the blast cell population is one of the ways a tumor can evade the immune surveillance of donor cells. This phenomenon is observed in approximately 30 % of relapses in patients with hemat